
Opinion|Videos|October 28, 2023
Considerations and Challenges Surrounding CAR-T Therapy and Bispecifics
Expert oncologists offer considerations for the use of CAR-T therapy and bispecific antibodies in follicular lymphoma and discuss potential challenges that may limit the use of these agents in clinical practice.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC
3
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
4
Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
5















































































